Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism ASK1 inhibitors(Apoptosis signal-regulating kinase 1 inhibitors), LRRK2 inhibitors(Leucine-rich repeat serine/threonine-protein kinase 2 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization Seal Rock Therapeutics, Inc.Startup |
Active Organization Seal Rock Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Discovery | US | Seal Rock Therapeutics, Inc.Startup | 13 Jun 2023 |
Parkinson Disease | Discovery | US | Seal Rock Therapeutics, Inc.Startup | 04 Jan 2023 |